News

We are pleased to announce that PEPperPRINT has signed a distribution agreement with 4A Biotech Co., Ltd. Under the terms of the agreement 4A Biotech Co., Ltd. has the exclusive marketing and sales rights for PEPperCHIP®...

[more]

We are pleased to announce the development of a new biomarker test for early diagnosis of rheumatoid arthritis in cooperation with PROGEN Biotechnik GmbH. During the next three years, the project will be funded by the Ge...

[more]

PEPperCHIP® Cancer Neoepitope Microarray

We invite you to meet us at the AACR Annual Meeting 2017 on April 1-5, 2017 in the exhibition area at booth #3548 in Washington, D.C.


At the AACR, PEPperPRINT will introduce the new PEPperCHIP® Cancer Neoepitope...

[more]

Systemic Lupus Erythematosus (SLE) is a multisystem autoimmune disease with mild to severe symptoms including a red rash, swollen joints and lymph nodes or chest pain. Although the suspected causes for SLE range from...

[more]

Janssen Diagnostics recently published a paper on the identification of immunodominant Onchocerca volvulus motifs in PLOS Neglected Tropical Diseases by using PEPperPRINT’s high-density peptide microarrays.

 

Epitope Substitution Scan of O. volvulus motifs

  ...

[more]

Hit Validation and Affinity Determination Service

Affinity determination is a crucial step in the development of antibodies and peptide target binders as well as in the analysis of peptide-protein interactions. After display or peptide microarray screenings, it is...

[more]

Presenter: Jill Roughan, PhD, Technical Sales Representative of PEPperPRINT GmbH, San Diego, USA


Webinar Date: Wednesday, September 7, 2016

 

Watch webinar video here

 

Antibodies are essential life science tools for therapeutics, basic...

[more]